Old	New	Differences
1	1
2	2
3	3
4	4	Req. No. 65 Page 1 1
5	5	2
6	6	3
7	7	4
8	8	5
9	9	6
10	10	7
11	11	8
12	12	9
13	13	10
14	14	11
15	15	12
16	16	13
17	17	14
18	18	15
19	19	16
20	20	17
21	21	18
22	22	19
23	23	20
24	24	21
25	25	22
26	26	23
27	27	24
28	28	1
29	29	2
30	30	3
31	31	4
32	32	5
33	33	6
34	34	7
35	35	8
36	36	9
37	37	10
38	38	11
39	39	12
40	40	13
41	41	14
42	42	15
43	43	16
44	44	17
45	45	18
46	46	19
47	47	20
48	48	21
49	49	22
50	50	23
51	51	24
52	52
53	53	STATE OF OKLAHOMA
54	54
55	55	1st Session of the 58th Legislature (2021)
56	56
57	57	SENATE BILL 23 By: Bullard
58	58
59	59
60	60
61	61
62	62
63	63	AS INTRODUCED
64	64
65	65	An Act relating to controlled dangerous subs tances;
66	66	amending 63 O.S. 2011, Section 2 -309, as last amended
67	67	by Section 1, Chapter 255, O.S. L. 2018 (63 O.S. Supp.
68	68	2020, Section 2-309), which relates to prescriptions;
69	69	exempting certain practitioners from electro nic
70	70	prescription requirement; limiting availability of
71	71	exemption; directing licensi ng boards to take certain
72	72	actions; and providing an effective date.
73	73
74	74
75	75
76	76
77	77	BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
78	78	SECTION 1. AMENDATORY 63 O.S. 2011, Section 2 -309, as
79	79	last amended by Section 1, Chapter 255, O. S.L. 2018 (63 O.S. Supp.
80	80	2020, Section 2-309), is amended to read as follows:
81	81	Section 2-309. A. 1. Except for dosages medically required
82	82	for a period not to exceed forty -eight (48) hours which are
83	83	administered by or on direction of a practitioner, other than a
84	84	pharmacist, or medication dispensed directly by a practitioner,
85	85	other than a pharmacist, to an ultimate user, no controlled
86	86	dangerous substance included in Schedule II, which is a pre scription
87	87	drug as determined under regulation promulgated by the Board of
88	88	Pharmacy, shall be dispensed without an ele ctronic prescription of a
89	89
90	90
91	91	Req. No. 65 Page 2 1
92	92	2
93	93	3
94	94	4
95	95	5
96	96	6
97	97	7
98	98	8
99	99	9
100	100	10
101	101	11
102	102	12
103	103	13
104	104	14
105	105	15
106	106	16
107	107	17
108	108	18
109	109	19
110	110	20
111	111	21
112	112	22
113	113	23
114	114	24
115	115	1
116	116	2
117	117	3
118	118	4
119	119	5
120	120	6
121	121	7
122	122	8
123	123	9
124	124	10
125	125	11
126	126	12
127	127	13
128	128	14
129	129	15
130	130	16
131	131	17
132	132	18
133	133	19
134	134	20
135	135	21
136	136	22
137	137	23
138	138	24
139	139
140	140	practitioner; provided, that in emergency situations, as prescribed
141	141	by the Board of Pharmacy by regulation, such drug may be dispensed
142	142	upon oral prescription reduced promptly to writing and filed by th e
143	143	pharmacist in a manner to b e prescribed by rules and regulations of
144	144	the Director of the Oklahoma State Bureau of Narcotics and Dangerous
145	145	Drugs Control.
146	146	2. Electronic prescribing shall be utilized for Schedules II,
147	147	III, IV, and V, subject to the requirem ents set forth in 21 CFR,
148	148	Section 1311 et seq.
149	149	3. An electronic prescription with electronic signature may
150	150	serve as an original prescription, subject to the requiremen ts set
151	151	forth in 21 CFR, Section 1311 et seq.
152	152	4. Prescriptions sh all be retained in conf ormity with the
153	153	requirements of this section and Section 2-307 of this title. No
154	154	prescription for a Schedule II substance may be refilled.
155	155	5. The electronic prescript ion requirement provided for in this
156	156	section shall not apply to p rescriptions for contro lled dangerous
157	157	substances issued by any of the following:
158	158	a. a person licensed to practice veterinary medicine,
159	159	b. a practitioner who experiences temporary technologica l
160	160	or electrical failure or other extenuating
161	161	circumstance that pr events the prescription from being
162	162	transmitted electronically; provided, however, that
163	163
164	164
165	165	Req. No. 65 Page 3 1
166	166	2
167	167	3
168	168	4
169	169	5
170	170	6
171	171	7
172	172	8
173	173	9
174	174	10
175	175	11
176	176	12
177	177	13
178	178	14
179	179	15
180	180	16
181	181	17
182	182	18
183	183	19
184	184	20
185	185	21
186	186	22
187	187	23
188	188	24
189	189	1
190	190	2
191	191	3
192	192	4
193	193	5
194	194	6
195	195	7
196	196	8
197	197	9
198	198	10
199	199	11
200	200	12
201	201	13
202	202	14
203	203	15
204	204	16
205	205	17
206	206	18
207	207	19
208	208	20
209	209	21
210	210	22
211	211	23
212	212	24
213	213
214	214	the practitioner documents the reason for this
215	215	exception in the medical record of the patient,
216	216	c. a practitioner, other than a pharmacist, who dispenses
217	217	directly to an ultimate user,
218	218	d. a practitioner who orders a control led dangerous
219	219	substance to be administered through an on -site
220	220	pharmacy in:
221	221	(1) a hospital as defined in Section 1 -701 of this
222	222	title,
223	223	(2) a nursing facility as defined in Section 1 -1902
224	224	of this title,
225	225	(3) a hospice inpatient fac ility as defined in
226	226	Section 1-860.2 of this title,
227	227	(4) an outpatient dialysis facility,
228	228	(5) a continuum of care facility as defined in
229	229	Section 1-890.2 of this title, or
230	230	(6) a penal institution listed in Section 509 of
231	231	Title 57 of the Oklahoma Statutes,
232	232	e. a practitioner who writes a p rescription to be
233	233	dispensed by a pharmacy located on federal property,
234	234	provided the practitioner documents the reason for
235	235	this exception in the medical record of the patient,
236	236	or
237	237
238	238
239	239	Req. No. 65 Page 4 1
240	240	2
241	241	3
242	242	4
243	243	5
244	244	6
245	245	7
246	246	8
247	247	9
248	248	10
249	249	11
250	250	12
251	251	13
252	252	14
253	253	15
254	254	16
255	255	17
256	256	18
257	257	19
258	258	20
259	259	21
260	260	22
261	261	23
262	262	24
263	263	1
264	264	2
265	265	3
266	266	4
267	267	5
268	268	6
269	269	7
270	270	8
271	271	9
272	272	10
273	273	11
274	274	12
275	275	13
276	276	14
277	277	15
278	278	16
279	279	17
280	280	18
281	281	19
282	282	20
283	283	21
284	284	22
285	285	23
286	286	24
287	287
288	288	f. a practitioner that has received a waiver or e xtension
289	289	from his or her lice nsing board, or
290	290	g. a practitioner who practices exclusively in one or
291	291	more medically underserved areas (MUA) as determined
292	292	by the Health Resources and Services Administration .
293	293	This exemption shall not be available for a
294	294	practitioner who has been subject t o disciplinary
295	295	action by the practitioner 's licensing board for a
296	296	violation related to the prescription of controlled
297	297	dangerous substances. The licensing board shall
298	298	communicate with and share necessary information with
299	299	the Oklahoma State Bureau of Narcot ics and Dangerous
300	300	Drugs Control for the purpose of enforcement of the
301	301	provisions of this subparagraph .
302	302	6. Electronic prescriptions shall n ot be utilized under the
303	303	following circumstances:
304	304	a. compound prescriptions containing t wo or more
305	305	commercially available products or two or more active
306	306	pharmaceutical ingredients,
307	307	b. compounded infusion prescriptions con taining two or
308	308	more commercially av ailable products or two or more
309	309	active pharmaceutical ingredients ,
310	310	c. prescriptions issued under approved research
311	311	protocols, or
312	312
313	313
314	314	Req. No. 65 Page 5 1
315	315	2
316	316	3
317	317	4
318	318	5
319	319	6
320	320	7
321	321	8
322	322	9
323	323	10
324	324	11
325	325	12
326	326	13
327	327	14
328	328	15
329	329	16
330	330	17
331	331	18
332	332	19
333	333	20
334	334	21
335	335	22
336	336	23
337	337	24
338	338	1
339	339	2
340	340	3
341	341	4
342	342	5
343	343	6
344	344	7
345	345	8
346	346	9
347	347	10
348	348	11
349	349	12
350	350	13
351	351	14
352	352	15
353	353	16
354	354	17
355	355	18
356	356	19
357	357	20
358	358	21
359	359	22
360	360	23
361	361	24
362	362
363	363	d. if the practitioner determines that an electronic
364	364	prescription cannot be issued in a time ly manner and
365	365	the condition of the patient is at risk.
366	366	7. A pharmacist who receives a written, oral or facsimile
367	367	prescription shall not be required to verify that the prescription
368	368	falls under one of the exceptions provided for in paragraph 6 of
369	369	this subsection. Pharmacists may continue to dispense medications
370	370	from otherwise valid written, oral or facsi mile prescriptions that
371	371	are consistent with the prov isions of this act.
372	372	8. Practitioners shall indicate in the health record of a
373	373	patient that an exception to the electronic prescription req uirement
374	374	was utilized.
375	375	9. All prescriptions issued pursuant to p aragraphs 5 and 6 of
376	376	this subsection shall be issued on an official prescription form
377	377	provided by the Oklahoma State Bureau of Narcotics and Dangerous
378	378	Drugs Control.
379	379	10. a. Effective January 1, 2020, practitioners shall
380	380	register with the Oklahoma State Bu reau of Narcotics
381	381	and Dangerous Drugs Control in ord er to be issued
382	382	official prescription forms. Such registration shall
383	383	include, but not be limited to, th e primary address
384	384	and the address of each place of business to be
385	385	imprinted on official prescription forms. Any change
386	386	to a registered practitioner 's registered address
387	387
388	388
389	389	Req. No. 65 Page 6 1
390	390	2
391	391	3
392	392	4
393	393	5
394	394	6
395	395	7
396	396	8
397	397	9
398	398	10
399	399	11
400	400	12
401	401	13
402	402	14
403	403	15
404	404	16
405	405	17
406	406	18
407	407	19
408	408	20
409	409	21
410	410	22
411	411	23
412	412	24
413	413	1
414	414	2
415	415	3
416	416	4
417	417	5
418	418	6
419	419	7
420	420	8
421	421	9
422	422	10
423	423	11
424	424	12
425	425	13
426	426	14
427	427	15
428	428	16
429	429	17
430	430	18
431	431	19
432	432	20
433	433	21
434	434	22
435	435	23
436	436	24
437	437
438	438	shall be promptly reported to the practitioner 's
439	439	licensing board and the Bureau by the practitioner in
440	440	a manner approved by the Bureau.
441	441	b. A practitioner's registration shall be without fee and
442	442	subject to approval by the Bureau. Such reg istration
443	443	shall be valid for a period of two (2) years and may
444	444	be denied, suspended or revoked by the Bu reau upon a
445	445	finding by the Bureau o r licensing board that the
446	446	registered practitioner has had any li cense to
447	447	practice a medical profession revoked or su spended by
448	448	any state or federal agency.
449	449	c. Where the Bureau has revoked the registration of a
450	450	registered practitioner, the Bureau may revok e or
451	451	cancel any official prescription forms in the
452	452	possession of the registered practiti oner. Any
453	453	revocation or any suspension shall require the
454	454	registered practitioner to return all unused official
455	455	prescription forms to the Bureau within fifteen (15)
456	456	calendar days after the date of the written
457	457	notification.
458	458	d. A practitioner that has had an y license to practice
459	459	terminated, revoked or suspended by a state or federal
460	460	agency may, upon restoration of such license or
461	461
462	462
463	463	Req. No. 65 Page 7 1
464	464	2
465	465	3
466	466	4
467	467	5
468	468	6
469	469	7
470	470	8
471	471	9
472	472	10
473	473	11
474	474	12
475	475	13
476	476	14
477	477	15
478	478	16
479	479	17
480	480	18
481	481	19
482	482	20
483	483	21
484	484	22
485	485	23
486	486	24
487	487	1
488	488	2
489	489	3
490	490	4
491	491	5
492	492	6
493	493	7
494	494	8
495	495	9
496	496	10
497	497	11
498	498	12
499	499	13
500	500	14
501	501	15
502	502	16
503	503	17
504	504	18
505	505	19
506	506	20
507	507	21
508	508	22
509	509	23
510	510	24
511	511
512	512	certificate, register to be issued official
513	513	prescription forms.
514	514	11. a. Except as provided in subparagraph f of this
515	515	paragraph, the Bureau shall issue official
516	516	prescription forms free of charge only to registered
517	517	practitioners in this state. Such forms shall not be
518	518	transferable. The number of off icial prescription
519	519	forms issued to a registered practitioner at a ny time
520	520	shall be at the discretion of the Bureau.
521	521	b. Official prescription forms issued to a registered
522	522	practitioner shall be imprinted only with the primar y
523	523	address and other addresses liste d on the registration
524	524	of the practitioner. Such prescriptions sh all be sent
525	525	only to the primary address of the regis tered
526	526	practitioner.
527	527	c. Official prescription forms issued to a registered
528	528	practitioner shall be used onl y by the practitioner to
529	529	whom they are issued.
530	530	d. The Bureau may revoke or cancel official prescript ion
531	531	forms in possession of registered practitioners when
532	532	the license of such practitioner is suspended,
533	533	terminated or revoked.
534	534	e. Official prescription form s of registered
535	535	practitioners who are deceased or who no longer
536	536
537	537
538	538	Req. No. 65 Page 8 1
539	539	2
540	540	3
541	541	4
542	542	5
543	543	6
544	544	7
545	545	8
546	546	9
547	547	10
548	548	11
549	549	12
550	550	13
551	551	14
552	552	15
553	553	16
554	554	17
555	555	18
556	556	19
557	557	20
558	558	21
559	559	22
560	560	23
561	561	24
562	562	1
563	563	2
564	564	3
565	565	4
566	566	5
567	567	6
568	568	7
569	569	8
570	570	9
571	571	10
572	572	11
573	573	12
574	574	13
575	575	14
576	576	15
577	577	16
578	578	17
579	579	18
580	580	19
581	581	20
582	582	21
583	583	22
584	584	23
585	585	24
586	586
587	587	prescribe shall be returned to the B ureau at a
588	588	designated address. If the registered pr actitioner is
589	589	deceased, it is the responsibility of the registered
590	590	practitioner's estate or lawful desig nee to return
591	591	such forms.
592	592	f. The Bureau may issue official prescription forms to
593	593	employees or agents of the Bureau and othe r government
594	594	agencies for the purpose of preventing, identifying,
595	595	investigating and prosecuting unacceptable or illegal
596	596	practices by providers and other persons and ass isting
597	597	in the recovery of overpayments under any program
598	598	operated by the state or paid f or with state funds.
599	599	Such prescription forms shall be issued for this
600	600	purpose only to individuals who are authorized to
601	601	conduct investigations on behalf of the Bureau or
602	602	other government agencies as part of their official
603	603	duties. Individuals and agencies receiving such
604	604	prescription forms for this purpose shall provide
605	605	appropriate assurances to the Bureau that adequate
606	606	safeguards and security measures are in place to
607	607	prevent the use of such prescription forms for
608	608	anything other than official government pur poses.
609	609	12. a. Adequate safeguards and security measures shall be
610	610	undertaken by registered practitioners holding
611	611
612	612
613	613	Req. No. 65 Page 9 1
614	614	2
615	615	3
616	616	4
617	617	5
618	618	6
619	619	7
620	620	8
621	621	9
622	622	10
623	623	11
624	624	12
625	625	13
626	626	14
627	627	15
628	628	16
629	629	17
630	630	18
631	631	19
632	632	20
633	633	21
634	634	22
635	635	23
636	636	24
637	637	1
638	638	2
639	639	3
640	640	4
641	641	5
642	642	6
643	643	7
644	644	8
645	645	9
646	646	10
647	647	11
648	648	12
649	649	13
650	650	14
651	651	15
652	652	16
653	653	17
654	654	18
655	655	19
656	656	20
657	657	21
658	658	22
659	659	23
660	660	24
661	661
662	662	official prescriptio n forms to assure against the
663	663	loss, destruction, theft or unauthorized use of the
664	664	forms. Registered practitioners shall ma intain a
665	665	sufficient but not e xcessive supply of such forms in
666	666	reserve.
667	667	b. Registered practitioners shall immediately notify the
668	668	Bureau, in a manner designated by the Bu reau, upon
669	669	their knowledge of the loss, destruction, theft or
670	670	unauthorized use of any of ficial prescription forms
671	671	issued to them, as well as the failure to receive
672	672	official prescription forms within a reasonable time
673	673	after ordering them from the Bureau.
674	674	c. Registered practitioners shall immediately notify the
675	675	Bureau upon their knowledge of an y diversion or
676	676	suspected diversion of drugs pursuant to the loss,
677	677	theft or unauthorized use of prescriptions.
678	678	B. 1. Except for dosa ges medically required for a period not
679	679	to exceed seventy-two (72) hours which are administered by o r on
680	680	direction of a practitioner, other than a pharm acist, or medication
681	681	dispensed directly by a practitioner, other than a pharmacist, to an
682	682	ultimate user, no controlled dangerous substance included in
683	683	Schedule III or IV, which is a prescription drug as d etermined under
684	684	regulation promulgated by the Board of Pharmacy, shall be dispensed
685	685	without an electronic prescription.
686	686
687	687
688	688	Req. No. 65 Page 10 1
689	689	2
690	690	3
691	691	4
692	692	5
693	693	6
694	694	7
695	695	8
696	696	9
697	697	10
698	698	11
699	699	12
700	700	13
701	701	14
702	702	15
703	703	16
704	704	17
705	705	18
706	706	19
707	707	20
708	708	21
709	709	22
710	710	23
711	711	24
712	712	1
713	713	2
714	714	3
715	715	4
716	716	5
717	717	6
718	718	7
719	719	8
720	720	9
721	721	10
722	722	11
723	723	12
724	724	13
725	725	14
726	726	15
727	727	16
728	728	17
729	729	18
730	730	19
731	731	20
732	732	21
733	733	22
734	734	23
735	735	24
736	736
737	737	2. Any prescription for a controlle d dangerous substance in
738	738	Schedule III , IV or V may not be filled or refilled more than six
739	739	(6) months after the date there of or be refilled more than f ive
740	740	times after the date of the prescription, unless renewed by the
741	741	practitioner.
742	742	C. Whenever it appear s to the Director of the Oklahoma S tate
743	743	Bureau of Narcotics and Dangerous Drugs Control that a drug not
744	744	considered to be a prescription drug under exist ing state law or
745	745	regulation of the Board of Pharmacy should be so considered because
746	746	of its abuse potential, the Director shall so advise t he Board of
747	747	Pharmacy and furnish to the Board all available data relevant
748	748	thereto.
749	749	D. 1. "Prescription", as used in this section, means a
750	750	written, oral or electronic order by a practitioner to a pharmacist
751	751	for a controlled dangerous substance for a parti cular patient, which
752	752	specifies the date of its issue, and the ful l name and address of
753	753	the patient and, if the contro lled dangerous substance is prescribed
754	754	for an animal, the species of the animal, the name and quantity o f
755	755	the controlled dangerous substanc e prescribed, the directions for
756	756	use, the name and address of the owner of the animal an d, if
757	757	written, the signature of the practitioner.
758	758	2. "Registered practitioner ", as used in this section, means a
759	759	licensed practitioner duly registered with the Oklahom a State Bureau
760	760
761	761
762	762	Req. No. 65 Page 11 1
763	763	2
764	764	3
765	765	4
766	766	5
767	767	6
768	768	7
769	769	8
770	770	9
771	771	10
772	772	11
773	773	12
774	774	13
775	775	14
776	776	15
777	777	16
778	778	17
779	779	18
780	780	19
781	781	20
782	782	21
783	783	22
784	784	23
785	785	24
786	786	1
787	787	2
788	788	3
789	789	4
790	790	5
791	791	6
792	792	7
793	793	8
794	794	9
795	795	10
796	796	11
797	797	12
798	798	13
799	799	14
800	800	15
801	801	16
802	802	17
803	803	18
804	804	19
805	805	20
806	806	21
807	807	22
808	808	23
809	809	24
810	810
811	811	of Narcotics and Dangerous Drugs Control to be iss ued official
812	812	prescription forms.
813	813	E. No person shall solicit, dispense, receive or deliver any
814	814	controlled dangerous substance through the mail, unless the u ltimate
815	815	user is personally known to the practitioner and circumstances
816	816	clearly indicate such method of delivery is in the b est interest of
817	817	the health and welfare of the ultimate user.
818	818	SECTION 2. This act shall become effective November 1, 2021.
819	819
820	820	58-1-65 DC 11/16/2020 4:57:11 PM

Oklahoma 2022 Regular Session

Oklahoma Senate Bill SB23 Compare Versions